Engine Biosciences is a venture-backed Singapore- and Silicon Valley-based company deciphering complex biology to unleash many impactful medicines. Our proprietary NetMAPPR platform integrates data science and machine learning, high-throughput biological experiments using our patented CombiGEM combinatorial genetics system, computational and wet lab chemistry, and drug discovery. We systematically analyze biological networks comprising millions-to-billions of gene interactions at greater speed and scale than conventionally possible, yielding promising drug targets for specific patient populations. Led by drug discovery and technology industry veterans and scientific pioneers, we are developing our growing pipeline of precision oncology therapeutics and working with partners to expand our impact. For more information, please visit www.enginebio.com